TIDMACRL

RNS Number : 7839V

Accrol Group Holdings PLC

16 December 2021

16 December 2021

ACCROL GROUP HOLDINGS PLC

("Accrol", the "Company" or the "Group")

AIM: ACRL

NOTICE OF HALF YEAR RESULTS

AND

ONLINE INVESTOR PRESENTATION

Accrol, the UK's leading independent tissue converter, announces that it will release its Half Year Results for the six months to 31 October 2021 on Tuesday, 18 January 2022.

An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.

As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Thursday, 20 January 2022 at 12.45pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H122.

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
 Richard Newman, Chief Financial Officer 
 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Jordan Warburton                  Tel: +44 (0) 161 831 1512 
Dominic King                                 Tel: +44 (0) 203 829 5000 
 
Liberum Capital Limited (Joint Broker)       Tel: +44 (0) 20 3100 2222 
Clayton Bush / Edward Thomas 
 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 078 
Keeley Clarke                                Tel: +44 (0) 7967 816 525 
 
                                              accrolpr@belvederepr.com

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP2.1bn UK retail tissue market.

For more information, please visit www.accrol.co.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORGPGUAPUPGGCA

(END) Dow Jones Newswires

December 16, 2021 02:00 ET (07:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Accrol Charts.